TLR2 sensing of F. nucleatum and S. sanguinis distinctly triggered gingival innate response.
Gingival tissue faces constant exposure to micro-organisms. It functions as part of the host response, an anti-microbial barrier that recognizes and discriminates between commensal and pathogenic bacteria. This study aimed to evaluate and compare the effects of cell wall extracts from different periodontal bacteria, commensals Streptococcus sanguinis and Fusobacterium nucleatum and the pathogen Porphyromonas gingivalis, on the innate immune response of gingival keratinocytes and the role of TLR2 in regulating this. We assayed mRNA levels to determine the expression of human beta-defensins (hbetaD2, hbetaD3), interleukin-1alpha, -1beta, 6 and 8 and matrix metalloproteinase-9. F. nucleatum extracts induced beta-defensin and inflammatory marker mRNA expression at higher levels than P. gingivalis. Extracts from the Gram-positive commensal S. sanguinis did not upregulate the host response. TLR2 extinction inhibited the upregulation of beta-defensin and cytokine transcripts by F. nucleatum extracts but, in contrast, led to a weak induction of hbetaD3 after challenge with S. sanguinis extracts. Although F. nucleatum strongly induces innate immune and inflammatory mediators, S. sanguinis limits their expression through TLR2. Together, our data demonstrate that gingival keratinocytes recognize and discriminate between Gram-positive and Gram-negative commensal extracts, in part through TLR2, to activate different signaling pathways of the innate immune host response.
Peyret-Lacombe
A
A
Département de Pharmacologie Cellulaire/PFDC Hotel Dieu, 2 rue Viguerie, 31025 Toulouse, Cedex 3, France.
Brunel
G
G
Watts
M
M
Charveron
M
M
Duplan
H
H
D015415:Biomarkers / Q000378:metabolism; D002473:Cell Wall / Q000737:chemistry / Q000276:immunology; D002478:Cells, Cultured; D016967:Fusobacterium nucleatum / Q000166:cytology / Q000276:immunology*; D020868:Gene Silencing; D005881:Gingiva / Q000166:cytology / Q000276:immunology* / Q000382:microbiology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007249:Inflammation / Q000276:immunology; D016209:Interleukin-8 / Q000235:genetics / Q000276:immunology; D015603:Keratinocytes / Q000166:cytology / Q000276:immunology; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism; D034622:RNA Interference; D015398:Signal Transduction / Q000502:physiology; D013298:Streptococcus sanguis / Q000166:cytology / Q000276:immunology*; D051195:Toll-Like Receptor 2 / Q000235:genetics / Q000276:immunology*; D023083:beta-Defensins / Q000235:genetics / Q000276:immunology
D015415:Biomarkers; C422950:DEFB103A protein, human; C106641:DEFB4A protein, human; D016209:Interleukin-8; D051195:Toll-Like Receptor 2; D023083:beta-Defensins; D020780:Matrix Metalloproteinase 9